X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with Fresenius Kabi Onco. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs FRESENIUS KABI ONCO. - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD FRESENIUS KABI ONCO. STRIDES SHASUN LTD/
FRESENIUS KABI ONCO.
 
P/E (TTM) x 14.1 22.1 63.7% View Chart
P/BV x 1.9 3.1 61.2% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 STRIDES SHASUN LTD   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-16
FRESENIUS KABI ONCO.
Mar-13
STRIDES SHASUN LTD/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs1,413176 802.6%   
Low Rs84879 1,080.3%   
Sales per share (Unadj.) Rs353.337.7 937.4%  
Earnings per share (Unadj.) Rs23.45.1 459.1%  
Cash flow per share (Unadj.) Rs41.06.7 609.6%  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs320.442.5 753.2%  
Shares outstanding (eoy) m89.35158.23 56.5%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x3.23.4 94.8%   
Avg P/E ratio x48.325.0 193.5%  
P/CF ratio (eoy) x27.618.9 145.7%  
Price / Book Value ratio x3.53.0 117.9%  
Dividend payout %21.40-   
Avg Mkt Cap Rs m100,98820,135 501.6%   
No. of employees `0004.71.2 407.1%   
Total wages/salary Rs m4,988703 709.4%   
Avg. sales/employee Rs Th6,730.05,176.2 130.0%   
Avg. wages/employee Rs Th1,063.6610.4 174.2%   
Avg. net profit/employee Rs Th445.5699.6 63.7%   
INCOME DATA
Net Sales Rs m31,5645,963 529.3%  
Other income Rs m1,21218 6,734.4%   
Total revenues Rs m32,7765,981 548.0%   
Gross profit Rs m5,2131,430 364.5%  
Depreciation Rs m1,573258 609.8%   
Interest Rs m1,803-26 -6,935.0%   
Profit before tax Rs m3,0491,216 250.7%   
Minority Interest Rs m1270-   
Prior Period Items Rs m-270-   
Extraordinary Inc (Exp) Rs m-371-68 544.7%   
Tax Rs m689342 201.2%   
Profit after tax Rs m2,089806 259.3%  
Gross profit margin %16.524.0 68.9%  
Effective tax rate %22.628.1 80.3%   
Net profit margin %6.613.5 49.0%  
BALANCE SHEET DATA
Current assets Rs m35,9495,102 704.7%   
Current liabilities Rs m19,4022,385 813.3%   
Net working cap to sales %52.445.6 115.1%  
Current ratio x1.92.1 86.6%  
Inventory Days Days71150 47.3%  
Debtors Days Days127113 111.9%  
Net fixed assets Rs m34,4785,148 669.7%   
Share capital Rs m894158 564.8%   
"Free" reserves Rs m22,6016,556 344.8%   
Net worth Rs m28,6326,732 425.3%   
Long term debt Rs m27,455952 2,883.3%   
Total assets Rs m76,59110,388 737.3%  
Interest coverage x2.7-45.8 -5.9%   
Debt to equity ratio x1.00.1 677.9%  
Sales to assets ratio x0.40.6 71.8%   
Return on assets %5.17.5 67.7%  
Return on equity %7.312.0 61.0%  
Return on capital %8.214.6 55.9%  
Exports to sales %48.174.5 64.6%   
Imports to sales %14.524.8 58.4%   
Exports (fob) Rs m15,1924,441 342.1%   
Imports (cif) Rs m4,5651,477 309.0%   
Fx inflow Rs m16,6125,298 313.6%   
Fx outflow Rs m5,2921,772 298.6%   
Net fx Rs m11,3203,525 321.1%   
CASH FLOW
From Operations Rs m7171,274 56.2%  
From Investments Rs m-22,284-1,204 1,850.5%  
From Financial Activity Rs m29,488-196 -15,037.0%  
Net Cashflow Rs m8,073-126 -6,391.9%  

Share Holding

Indian Promoters % 27.7 0.0 -  
Foreign collaborators % 0.0 81.0 -  
Indian inst/Mut Fund % 37.8 0.3 12,600.0%  
FIIs % 8.6 9.6 89.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 9.1 284.6%  
Shareholders   56,241 42,599 132.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   NOVARTIS  TORRENT PHARMA  DISHMAN PHARMA  CIPLA  ABBOTT INDIA  

Compare STRIDES SHASUN LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Tata Global Beverages Surges 8.3%(Closing)

Indian share markets snapped their losing streak of last week and finished the trading day on a strong note due to strong buying momentum in FMCG stocks, metal stocks and auto stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Aug 16, 2017 (Close)

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 5-YR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS